REQUEST A DEMO
Total
USD $0.00
Search more companies

Lesaffre Singapore Pte. Ltd. (Singapore)

Main Activities: Corporate, Subsidiary, and Regional Managing Offices
Secondary Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Lesaffre Singapore Pte. Ltd. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Primary Business Activity: activities of head and regional head offices; centralised administrative offices and subsidiary management offices; Secondary Business Activity: research and experimental development on medical science

Headquarters
23 Serangoon North Avenue 5, #06-02 Btc Centre, Singapore
Singapore; Singapore; Postal Code: 554530

Contact Details: Purchase the Lesaffre Singapore Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Lesaffre Singapore Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Lesaffre Singapore Pte. Ltd. report to view the information.
Incorporation Date:
July 28, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lesaffre Singapore Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
17.94%
Total operating revenue
17.94%
Net Profit (Loss) for the Period
-84.65%
Total assets
15.47%
Total equity
-36.16%
Net Profit Margin
-0.84%
Return on Equity (ROE)
-8.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?